Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin

Journal of Immunotherapy

Volumn 24, Issue 6, 2001, Pages 472-481

  Li, M ^a   Huang, X ^a   Zhu, Z ^a   Wong, M ^a   Watkins, S ^a   Zhao, Q ^a   Herberman, R ^a   Gorelik, E ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Combined antiangiogenic and immune therapy; Endostatin; Tumor immunogenicity; Tumor vaccination

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; LEWIS CARCINOMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CANCER VACCINES; CARCINOMA, LEWIS LUNG; COLLAGEN; ENDOSTATINS; FEMALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; VACCINATION;

EID: 0035200463     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200111000-00004     Document Type: Article

References (28)

1. Angiogenesis and angiogenesis inhibition: An overview
2. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
3. Angiostatin induces and sustains dormancy of human primary tumors in mice
4. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
5. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
6. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
7. Cancer tumor antigens
8. Human tumor antigens recognized by T-cells
9. Cancer vaccines based on the identification of genes encoding cancer regression antigens
10. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
11. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation
12. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation
13. Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis
14. Up-regulation of tumor cell sensitivity to natural cell-mediated cytotoxicity by UV light irradiation
15. Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor
16. Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity
17. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma
18. MHC class I genes controlling the metastatic phenotype of tumor cells
19. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene
20. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
21. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation
22. Tumor necrosis factor
23. Inhibition of angiogenesis in vivo by interleukin 12
24. Inhibition of angiogenesis by interleukin 4
25. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
26. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
27. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
28. Combined effects of angiostatin and ionizing radiation in antitumour therapy